DuPont de Nemours, Inc. Stock 12‑Month Price Target Raised to $57.64, Implies 24% Upside
Analysts have raised the 12-month price target for DuPont de Nemours, Inc. (DD) stock to $57.64, up from $56.75, with forecasts ranging from $52 to $7...
Analysts have raised the 12-month price target for DuPont de Nemours, Inc. (DD) stock to $57.64, up from $56.75, with forecasts ranging from $52 to $7...
Neutral
DuPont de Nemours Inc. (DD) shares are trading in the high-$40s, with Wall Street analysts largely maintaining a Moderate Buy rating and an average pr...
Neutral
The Goldman Sachs Group has initiated coverage on DuPont de Nemours (NYSE:DD) with a "neutral" rating and a price target of $53.00, suggesting a poten...
Bullish
DuPont announced that its U.S.-based healthcare manufacturing operations are now powered by 100% renewable electricity through the purchase of additio...
Neutral
DuPont de Nemours Inc. (DD) has seen significant stock performance, rising 17.1% year-to-date and 64% over the past 52 weeks, outperforming the Nasdaq...
Neutral
DuPont de Nemours, Inc. (NYSE: DD) announced the results of its 2026 Annual Meeting of Stockholders, including the approval of a 1-for-3 reverse stock...